← Back to Search

IN-PEACE Dementia Care Coordination for Dementia (IN-PEACE Trial)

N/A
Waitlist Available
Led By Greg A Sachs, MD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Inclusion Criteria: Community-dwelling and living in the Indianapolis metropolitan area; Patient with an established diagnosis of dementia of any etiology; Dementia in the moderate (FAST stage 5) to severe stage (FAST 6-7); and English-speaking Primary caregiver informant enrolled in study.
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-24 months
Awards & highlights

IN-PEACE Trial Summary

This trial is investigating an intervention to improve the care of patients with dementia and their caregivers. The intervention is a combination of an existing evidence-based intervention for dementia care and an innovative intervention for palliative care in dementia. The trial will enroll 200 patient-caregiver dyads and follow them for 24 months. The primary aim is to test the effect of the intervention on patients' neuropsychiatric symptoms.

IN-PEACE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

IN-PEACE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Neuropsychiatric Inventory Questionnaire (NPI-Q)
Secondary outcome measures
Caregiver Mood, Distress
Symptom Outcomes

IN-PEACE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: IN-PEACE Dementia Care CoordinationExperimental Treatment1 Intervention
In-PEACE intervention arm will have monthly contact with a dementia care coordinator (DCC) to to identify symptoms the person with memory problems is having, including: pain, sadness, or other symptoms. The Dementia Care Coordinator will consult with the project clinical team to develop a plan of care utilizing standardized protocols to reduce the burdens of disease associated symptoms and behaviors.
Group II: Usual CareActive Control1 Intervention
The usual care arm will have access to education and informational materials from the local chapter of the Alzheimer's Association and other community resources and will be reminded of these resources throughout the study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
IN-PEACE Dementia Care Coordination
2018
N/A
~410

Find a Location

Who is running the clinical trial?

Regenstrief Institute, Inc.OTHER
26 Previous Clinical Trials
98,075 Total Patients Enrolled
4 Trials studying Dementia
23,670 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,658 Previous Clinical Trials
28,004,124 Total Patients Enrolled
263 Trials studying Dementia
23,622,689 Patients Enrolled for Dementia
Indiana UniversityLead Sponsor
977 Previous Clinical Trials
982,911 Total Patients Enrolled
17 Trials studying Dementia
53,323 Patients Enrolled for Dementia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities for new participants to join this investigation?

"Clinicaltrials.gov divulges that, while the trial was initially posted on December 1st 2018 and updated as recently as February 15th 2022, it is not presently enlisting patients for participation. Nevertheless, there are currently 397 other clinical trials actively recruiting participants."

Answered by AI
Recent research and studies
~64 spots leftby Mar 2025